Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Longitudinal Observation Translational Study to Evaluate Phenotypes, Endotypes and Biomarkers in Chinese Patients With NCFBE

NCT07245407 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07245407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07245407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Longitudinal Observation Translational Study to Evaluate Phenotypes, Endotypes and Biomarkers in Chinese Patients With NCFBE
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Active, not recruiting
Start date
October 27, 2025
Completion date
July 29, 2027
Enrollment
251 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

non-cystic fibrosis bronchiectasis